Disclosures for "Neurite Orientation Dispersion and Density Imaging (NODDI) and Immune System Response in Temporal Lobe Epilepsy"
-
Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
-
Rodolphe Nenert has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Mueller has nothing to disclose.
-
Mrs. Sharma has nothing to disclose.
-
Dr. Qin has nothing to disclose.
-
Dr. Benveniste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SONTAG BRAIN TUMOR FOUNDATION. Dr. Benveniste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WINSHIP Cancer Center, Emory.